Green Cross has ranked among the top-searched stocks for 15 days over the past month.


As of 2:30 p.m. on November 19, Green Cross is trading at 388,500 KRW, up 1.17% from the previous day. This represents a 68.91% increase compared to October 22. Green Cross is known as a pharmaceutical company specializing in blood products and vaccines.

Today, foreign investors have made a net purchase of 7,000 shares of Green Cross, while institutional investors have made a net purchase of 1,000 shares, according to provisional data. Over the past five days, individual investors have made a net sale of 77,963 shares, while foreign investors and institutions have made net purchases of 69,538 shares and 890 shares, respectively.


On November 11, Green Cross became a market topic as it was identified as the "timing for newly reflecting vaccine CMO value."





[Table] Net Buying/Selling Volume by Foreign and Institutional Investors (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was automatically generated in real time by a news automation algorithm jointly developed by Asia Economy and Thinkpool, a financial AI specialist company.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing